ALYSSA DOMBROSKY: Open Payments
NPI 1306559331 · HOBOKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 22 payments from 7 companies in 2025. Trend: 2023 $27 · 2024 $0 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Novo Nordisk Inc | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 4 | $48 |
| Gilead Sciences, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: Korlym, ENTYVIO, VOQUEZNA, Ozempic, Yeztugo, Cologuard Collection Kit, MOUNJARO, Rybelsus.
Industry payments across NJ — which companies pay providers there.
